Drugs / DA-002
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06501924 | Jan → Oct 2025 overdue | baldness, male pattern | Applied Biology, Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DA-002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06501924 ↗ |
| Route | Topical | “Topical Alpha 1 Agonist (GRAS)” NCT06501924 ↗ |